Cargando…

Recurrence Patterns and Survival Outcomes in Chinese Patients with Surgically Treated Recurrent Ovarian Clear Cell Carcinoma: A Single Institutional Analysis of 45 Cases

BACKGROUND: To evaluate the recurrence patterns and survival outcomes of surgically treated relapsed ovarian clear cell carcinoma (OCCC) patients. METHODS: We performed a comprehensive retrospective analysis of all the patients who underwent secondary debulking from 2004/10 to 2019/04. RESULTS: In t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ye, Shuang, Zhou, Shuling, Chen, Wei, Xiang, Libing, Wu, Xiaohua, Yang, Huijuan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2020
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7012237/ https://www.ncbi.nlm.nih.gov/pubmed/32104073 http://dx.doi.org/10.2147/CMAR.S242129

Ejemplares similares

(18)F-FDG PET/CT-based metabolic metrics in recurrent tumors of ovarian clear cell carcinoma and their prognostic implications
por: Ye, Shuang, et al.
Publicado: (2019)

The role of [Formula: see text] F-FDG PET/CT-based quantitative metabolic parameters in patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2020)

Genomic profiling of ovarian clear cell carcinoma in Chinese patients reveals potential prognostic biomarkers for survival
por: Ye, Shuang, et al.
Publicado: (2023)

Fibrinogen/albumin ratio as a promising predictor of platinum response and survival in ovarian clear cell carcinoma
por: Chen, Wei, et al.
Publicado: (2022)

The surgical outcomes and perioperative complications of bowel resection as part of debulking surgery of advanced ovarian cancer patients
por: Ye, Shuang, et al.
Publicado: (2022)

Serum D-dimer, albumin and systemic inflammatory response markers in ovarian clear cell carcinoma and their prognostic implications
por: Chen, Wei, et al.
Publicado: (2020)

The frequency and clinical implication of mismatch repair protein deficiency in Chinese patients with ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

Risk Factors for Recurrence of Ovarian Endometriosis in Chinese Patients Aged 45 and Over
por: He, Zheng-Xing, et al.
Publicado: (2018)

Changes in peripheral lymphocyte populations in patients with advanced/recurrent ovarian cancer undergoing splenectomy during cytoreductive surgery
por: Chen, Wei, et al.
Publicado: (2021)

Establishment and molecular characterization of a human ovarian clear cell carcinoma cell line (FDOV1)
por: Jiang, Wei, et al.
Publicado: (2018)

Transcriptomic recurrence score improves recurrence prediction for surgically treated patients with intermediate‐risk clear cell kidney cancer
por: Patel, Neal, et al.
Publicado: (2022)

Diaphragmatic Surgery and Related Complications In Primary Cytoreduction for Advanced Ovarian, Tubal, and Peritoneal Carcinoma
por: Ye, Shuang, et al.
Publicado: (2017)

PIK3CA mutation analysis in Chinese patients with surgically resected cervical cancer
por: Xiang, Libing, et al.
Publicado: (2015)

Pembrolizumab and lenvatinib in recurrent ovarian clear cell carcinoma resistant to chemotherapy
por: McNamara, Blair, et al.
Publicado: (2023)

Survival benefit of taxane plus platinum in recurrent ovarian cancer with non-clear cell, non-mucinous histology
por: Kajiyama, Hiroaki, et al.
Publicado: (2014)

Conditional survival and recurrence of remnant gastric cancer after surgical resection: A multi‐institutional study
por: Chen, Qi‐Yue, et al.
Publicado: (2019)

Local recurrence of prostatic ductal adenocarcinoma despite clear surgical margins
por: Merrett, Christopher, et al.
Publicado: (2018)

Repurposing Drugs in Controlling Recurrent Platinum-Resistant Clear-Cell Ovarian Cancer
por: Sinsuwan, Woraporn, et al.
Publicado: (2023)

Prognostic Factors and Survival in Patients Treated Surgically for Recurrent Metastatic Uterine Leiomyosarcoma
por: Hoang, Han L. T., et al.
Publicado: (2014)

Integrative genomic and transcriptomic analysis reveals immune subtypes and prognostic markers in ovarian clear cell carcinoma
por: Ye, Shuang, et al.
Publicado: (2022)

Surgical Therapy of Ovarian Endometrioma: Recurrence and Pregnancy Rates
por: Maul, Lara V., et al.
Publicado: (2014)

Survival benefits of surgical resection in recurrent cholangiocarcinoma
por: Song, Sun Choon, et al.
Publicado: (2011)

Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma
por: Zhou, Shao-Lai, et al.
Publicado: (2021)

A Comprehensive Model for Predicting Recurrence and Survival in Cases of Chinese Postoperative Invasive Breast Cancer
por: Xie, Xianhe, et al.
Publicado: (2017)

Urachal Carcinoma with Peritoneal Dissemination Treated with Chemotherapy and Surgical Resection Leading to Prolonged Survival with No Recurrence
por: Yasui, Masato, et al.
Publicado: (2018)

Conditional Survival Analysis Demonstrates that Recurrence Risk of Surgically Treated Hepatocellular Carcinoma Evolves with Time
por: Park, Yong Keun, et al.
Publicado: (2017)

Distal pancreatectomy with splenectomy for the management of splenic hilum metastasis in cytoreductive surgery of epithelial ovarian cancer
por: Xiang, Libing, et al.
Publicado: (2016)

Clinicopathological Determinants of Recurrence Risk and Survival in Mucinous Ovarian Carcinoma
por: Hollis, Robert L., et al.
Publicado: (2021)

Comprehensive analysis of targetable oncogenic mutations in chinese cervical cancers
por: Xiang, Libing, et al.
Publicado: (2014)

Recurrent metastatic clear cell renal carcinoma with sarcomatoid dedifferentiation treated with surgery and Cabozantinib
por: Boustany, Johnny, et al.
Publicado: (2020)

Tumor miR-125b predicts recurrence and survival of patients with clear-cell renal cell carcinoma after surgical resection
por: Fu, Qiang, et al.
Publicado: (2014)

Timing and duration of bevacizumab treatment and survival in patients with recurrent ovarian, fallopian tube, and peritoneal cancer: a multi-institution study
por: Ghezelayagh, Talayeh S., et al.
Publicado: (2023)

A case of severe encephalitis while on PD-1 immunotherapy for recurrent clear cell ovarian cancer
por: Burke, Morgan, et al.
Publicado: (2018)

Case Series and a Literature Review: Two Ovarian Clear Cell Carcinoma Cases with Recurrent Endometriosis
por: Yin, Dan, et al.
Publicado: (2023)

73. PREDICTION OF A SECOND LOCAL RECURRENCE IN SURGICALLY TREATED RECURRENT BRAIN METASTASES PATIENTS
por: Tewarie, Ishaan, et al.
Publicado: (2020)

Cumulative Recurrence Rate and Risk Factors for Recurrent Abdominal Wall Endometriosis after Surgical Treatment in a Single Institution
por: Kim, Su Jin, et al.
Publicado: (2022)

Conditional Survival of Surgically Treated Patients with Lung Cancer: A Comprehensive Analyses of Overall, Recurrence-Free, and Relative Survival
por: Shin, Dong Wook, et al.
Publicado: (2021)

The presence of living endometrial cells in ovarian endometriotic cyst fluid may contribute to the recurrence of endometriosis after surgical excision of endometriomas
por: Xu, Xinxin, et al.
Publicado: (2022)

Post intravitreal bevacizumab recurrent Burkholderia cepacia endophthalmitis treated with clear lens extraction in an African
por: Okonkwo, Ogugua Ndubuisi, et al.
Publicado: (2020)

Effect of delayed palliative chemotherapy on survival of patients with recurrent ovarian cancer
por: Pyeon, Seung Yeon, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_5pk1nst02inm6gp9525o9vkah5